Republicans in Congress shot down attempts by Democrats to addhundreds of millions of dollars to a bill aimed at preventing andtreating opioid abuse.

|

Republicans from the Senate and House who were part of aconference committee crafting a final bill to be voted on in bothchambers voted down amendments offered by Democrats that would havebrought the bill’s price tag up to $920 million. The bill currentlyonly includes $85 million over five years for treatmentefforts.

|

Democratic aides told The New York Times on Thursday therejection of the additional funding could mean that the minorityparty will not support the final bill, but The Hill reported onFriday that many Democrats would ultimately support the bill,despite their frustration with the low level of funding.

|

Both the House and Senate are scheduled to vote on the bill onFriday. The only realistic way for Democrats to block the billwould be to mount a filibuster in the Senate. Atleast 41 Democrats would be needed to prevent a vote on thebill.

|

Rep. Xavier Becerra, D-Calif., the chairman of the HouseDemocratic caucus, described the final bill as little more than asymbolic expression of support for combating the opioid epidemic that hasravaged communities across the country over the past decade.

|

"It's becoming a bit of a joke to say we're concerned and wantto do something, when the only thing we'll do is shell of what itactually takes," he told The Times.

|

President Obama echoed those sentiments through White Housespokesman Josh Earnest.

|

“Passing a bill that is doing little more than paying lipservice to the problem falls woefully short of Congress’s basicresponsibility," said Earnest, who left the possibility of a vetoopen.

|

Treatment advocates who are hoping for more funding might winsome consolation from Republicans, who are considering a separatehealth bill that would authorize more than $500 million for opioidtreatment.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.